Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Pediatric Blood & Cancer|December 6, 2019
Metabolomic profiling in neuroblastomaGuillermo Quintás, Yania Yáñez, Pablo Gargallo, et al.Pathology Oncology Research : POR|October 28, 2019
Review: Ewing Sarcoma PredispositionPablo Gargallo, Yania Yáñez, Antonio Juan, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 18, 2024
Exploring patients and caregivers needs and experiences in oncological physiotherapy: a call for collaborative careAlmudena Medina-Rincón, Marta San Miguel-Pagola, Pablo Gargallo-Aguarón, et al.International Journal of Retina and Vitreous|September 4, 2021
Retinoblastoma and mosaic 13q deletion: a case reportPablo Gargallo, Silvestre Oltra, Julia Balaguer, et al.BMC Medical Genomics|December 2, 2023
Novel intragenic deletion within the FXN gene in a patient with typical phenotype of Friedreich ataxia: may be more prevalent than we think?Cinthia Aguilera, Anna Esteve-Garcia, Carlos Casasnovas, et al.International Journal of Molecular Sciences|September 28, 2021
Pharmacogenetics in Neuroblastoma: What Can Already Be Clinically Implemented and What Is Coming Next?Gladys G Olivera, Andrea Urtasun, Luis Sendra, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 17, 2025
Perceptions about oncological physiotherapy among health and social care professionals and cancer care managers: a co-design approach for implementation strategiesMarta San Miguel-Pagola, Almudena Buesa-Estéllez, Pablo Gargallo-Aguarón, et al.Journal of Personalized Medicine|April 30, 2021
Next-Generation Sequencing Identifies Potential Actionable Targets in Paediatric SarcomasAntonio Juan Ribelles, Pablo Gargallo, Pablo Berlanga, et al.Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Pharmacogenetics implementation in the clinics: information and guidelines for germline variantsGladys Olivera, Luis Sendra, María José Herrero, et al.Scientific Reports|February 2, 2020
Publisher Correction: Clinical Features of Neuroblastoma With 11q Deletion: An Increase in Relapse Probabilities In Localized And 4S StagesAntonio Juan Ribelles, Sandra Barberá, Yania Yáñez, et al.Pageof 2